Disease Stabilization with MEK Inhibitors in NF1-Associated Plexiform Neurofibromas: A Systematic Review and Meta-Analysis with Subgroup Analyses by Age and Study Design.

Sanikommu S, Santos AN, Dawoud BM, Levy AS, Komotar RJ, Lu VM

Open source

DOI
10.1007/s40263-026-01316-6
Published
2026 Sep
Container
CNS drugs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40263-026-01316-6,
  title = {Disease Stabilization with MEK Inhibitors in NF1-Associated Plexiform Neurofibromas: A Systematic Review and Meta-Analysis with Subgroup Analyses by Age and Study Design.},
  author = {Sanikommu S and Santos AN and Dawoud BM and Levy AS and Komotar RJ and Lu VM},
  year = {2026},
  journal = {CNS drugs},
  doi = {10.1007/s40263-026-01316-6},
  url = {https://doi.org/10.1007/s40263-026-01316-6}
}

RIS

TY  - JOUR
TI  - Disease Stabilization with MEK Inhibitors in NF1-Associated Plexiform Neurofibromas: A Systematic Review and Meta-Analysis with Subgroup Analyses by Age and Study Design.
AU  - Sanikommu S
AU  - Santos AN
AU  - Dawoud BM
AU  - Levy AS
AU  - Komotar RJ
AU  - Lu VM
PY  - 2026
JO  - CNS drugs
DO  - 10.1007/s40263-026-01316-6
UR  - https://doi.org/10.1007/s40263-026-01316-6
ER  - 

APA

S, S., AN, S., BM, D., AS, L., RJ, K., & VM, L. (2026). Disease Stabilization with MEK Inhibitors in NF1-Associated Plexiform Neurofibromas: A Systematic Review and Meta-Analysis with Subgroup Analyses by Age and Study Design.. CNS drugs. https://doi.org/10.1007/s40263-026-01316-6

Source records